Get the Stockscreener App
794.68
0.46%
4.2376
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corp stock is traded at $794.68, with a volume of 420.02K.
It is up +0.46% in the last 24 hours and up +9.50% over the past month.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$790.44
Open:
$792.63
24h Volume:
420.02K
Relative Volume:
0.43
Market Cap:
$95.54B
Revenue:
$403.43B
Net Income/Loss:
$5.10B
P/E Ratio:
20.66
EPS:
38.4657
Net Cash Flow:
$5.41B
1W Performance:
+4.91%
1M Performance:
+9.50%
6M Performance:
-2.63%
1Y Performance:
+10.63%
1-Day Range:
$791.82
$800.36
1-Week Range:
$759.25
$800.36
52-Week Range:
$637.00
$999.00
Mckesson Corp Stock (MCK) Company Profile
Name
Mckesson Corp
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corp
|
794.79 | 95.01B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
283.71 | 54.72B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
222.77 | 50.66B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
80.02 | 8.98B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.37 | 1.19B | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corp Stock (MCK) Latest News
McKesson CEO Brian S. Tyler sells $3.76m in common stock - Investing.com Nigeria
McKesson (NYSE: MCK) CEO sells 4,929 shares under 10b5-1 plan - Stock Titan
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
McKesson, Rite Aid Trust Clash Over Ch. 11 Claims Transfer - Law360
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
McKesson (NYSE: MCK) proposes sale of 2,181 and 2,748 vested shares - Stock Titan
Insider Sell: Rutledge Napoleon B JR Sells Shares of McKesson Co - GuruFocus
McKesson Corp. stock underperforms Monday when compared to competitors - MarketWatch
McKesson SVP, controller & CAO sells $101,612 in common stock By Investing.com - Investing.com Canada
McKesson SVP, controller & CAO sells $101,612 in common stock - Investing.com
McKesson (NYSE: MCK) CAO reports 133-share open-market sale under 10b5-1 plan - Stock Titan
MCK News | MCKESSON CORP (NYSE:MCK) - ChartMill
McKesson unit prices $2.25 billion leveraged loan ahead of IPO - MSN
McKesson (MCK) Valuation Check After Recent Share Price Rebound And Mixed Fundamental Signals - Yahoo Finance
Airbnb, McKesson, Gilead and more set to report earnings Thursday - Investing.com
Here is What Analysts Are Saying About McKesson Corporation (MCK) - Insider Monkey
McKesson Corp stock (US58155Q1031): trading near highs as investors digest latest earnings and valua - AD HOC NEWS
Deals tracker: Tennessee senior care operator spends $50M for 5 facilities - Modern Healthcare
Argus Adjusts Price Target on McKesson to $850 From $1,050, Maintains Buy Rating - Moomoo
McKesson (MCK) Stock Forecast and Price Target 2026 $MCK - MarketBeat
BofA cuts McKesson stock price target on GLP-1 headwinds - Investing.com
McKesson Corp stock (US58155Q1031): shares hold near record territory after solid fiscal Q4 results - AD HOC NEWS
BofA cuts McKesson stock price target on GLP-1 headwinds By Investing.com - Investing.com Nigeria
Insider Sell: Thomas Rodgers Sells Shares of McKesson Corp (MCK) - GuruFocus
MCK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
McKesson Unit Prices $2.25 Billion Leveraged Loan Ahead of IPO - Bloomberg.com
McKesson EVP Thomas L. Rodgers sells $604,420 of company stock - Investing.com UK
McKesson EVP Thomas L. Rodgers sells $604,420 of company stock By Investing.com - Investing.com India
[Form 4] MCKESSON CORP Insider Trading Activity - Stock Titan
Is McKesson stock underperforming the Dow? - MSN
We Ran A Stock Scan For Earnings Growth And McKesson (NYSE:MCK) Passed With Ease - Yahoo Finance
Are Wall Street analysts predicting McKesson stock will climb or sink? - MSN
Is McKesson Stock Underperforming the Dow? - Yahoo Finance
McKesson (MCK) Secures $1.25 Billion Investment from Apollo for MMS Spin-Off - GuruFocus
Insider Sell: Leann Smith Sells Shares of McKesson Corp (MCK) - GuruFocus
McKesson EVP LeAnn B Smith sells $1.33 million in company stock - Investing.com Australia
McKesson EVP LeAnn B Smith sells $1.33 million in company stock By Investing.com - Investing.com South Africa
McKesson (NYSE: MCK) EVP sells 1,810 shares under 10b5-1 plan - Stock Titan
Thomas L. Rodgers to sell Common shares (NYSE: MCK) under Rule 144 - Stock Titan
McKesson completes $1.25 billion Apollo investment in medical unit By Investing.com - Investing.com
McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions - Yahoo Finance
Apollo's $1.25B investment values McKesson MMS at about $13B - Stock Titan
McKesson (MCK) CFO Kenny Cheung receives multi-year RSU awards - Stock Titan
McKesson (MCK) EVP & CFO Kenny Cheung files initial insider Form 3 - Stock Titan
Thomas L. Rodgers sells 2,388 MCK shares (MCK) - Stock Titan
McKesson (NYSE: MCK) files Form 144; Proposed sale notice after stock vesting - Stock Titan
McKesson Corp. stock underperforms Friday when compared to competitors - MarketWatch
Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), McKesson (MCK) and Biohaven Ltd. (BHVN) - The Globe and Mail
McKesson EVP, chief strategy & BDO Thomas Rodgers sells $1.8m in stock - Investing.com UK
Mckesson Corp Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):